Previous studies explained the contribution of zinc deficiency to the increased risk of VOCs in SCD patients because zinc deficiency increases gene expression and production of interleukin 1β (IL-1β) and tumor necrosis factor α (TNF-α). Here, TNF is linked to Zinc deficiency.